Medical Device Coatings

Published - May 2012| Analyst - Jim Wilson| Code - HLC049C
Market Research Report Single User License: $2750 Member Price: FREE

Report Highlights

The global medical device coating market reached $4.8 billion in 2010 and $5.4 billion in 2011. The market is expected to grow from $5.7 billion in 2012 to nearly $8 billion in 2017, a five-year compound annual growth rate (CAGR) of 6.7%.

SCOPE AND FORMAT

This study looks at medical device coatings and surface treatments from the perspective of both the supply and demand side of the equation, that is from coating manufacturers who supply the materials, the medical device companies which use it and the members of the healthcare that influence purchases.

Consistent with the scope of the study, the format of this report is arranged to present its five-year forecasts as a series of tables.  Each of those tables presents U.S. current dollar demand values for coatings and surface processes for 2010 and 2011 and a five-year period from 2012 through 2017.  Separate sets of forecasts are presented for the:

  • Eight types of coatings and surface treatment technologies.
  • 19 healthcare areas that correspond to FDA medical device review panels.
  • United States, European Union, other developed nations and the rest of the world.

TECHNOLOGIES

We present forecasts for the seven basic types of coatings plus surface treatment technologies.  Coatings are grouped on the basis of their most distinguishing chemical or physical characteristic.  Surface treatments are defined as those processes that alter the surface of a device without adding a chemical or physical agent.  For example, we characterize chrome plating as a type of alloy coating, rather than a surface treatment.  The eight types of technology addressed in this study are:

  • Alloy.
  • Ceramic.
  • Combination.
  • Energy-absorbing.
  • Energy-emitting.
  • Micro and nano.
  • Protective polymer.
  • Surface treatment.

HEALTHCARE AREAS

Our forecasts by healthcare area follow the disciplinary divisions used by the FDA in creating its medical device review panels.  The 19 healthcare areas are:

  • Anesthesiology.
  • Cardiovascular.
  • Chemistry.
  • Dental.
  • Ear, nose and throat.
  • Gastroenterology and urology.
  • General and plastic surgery.
  • General hospital use.
  • Hematology.
  • Immunology.
  • Microbiology
  • Neurology.
  • Obstetrics and gynecology.
  • Ophthalmology.
  • Orthopedics.
  • Pathology.
  • Physical medicine.
  • Radiology.
  • Toxicology.

COUNTRIES AND REGIONS

In this study we report both global and regional forecast values for the following countries and regions:

  • United States.
  • European Union.
  • Other developed nations.
  • The Rest of the world.

The forecast values for the United States include Puerto Rico, a major manufacturing center for many medical devices labeled as made in the United States.  The EU forecast contains only those 27 countries that were full members on March 1, 2012.  Assignment to one of the remaining groups is based on the World Bank’s determination of each economy’s per capita gross national income (GNI) on July 1, 2011.  Other developed nations are those where the per capita GNI is $12,276 and above.  The rest of the world forecast group contains countries for which the World Bank reported a per capita GNI of $12,275 and below.

Each of the 191 countries for which BCC Research deemed there was sufficient forward-looking healthcare information to permit forecasting has been assigned to one and only one regional group.  Thus, the developed nations group excludes the United States and EU member countries.  In tables that identify countries, we use their common rather than formal names; for example, Venezuela rather than The Bolivarian Republic of Venezuela.  We also distinguish among Communist China-Mainland and its two special administrative regions of China-Hong Kong and China-Macau.  We refer to Taiwan as China-Taiwan.

ANALYST'S CREDENTIALS

Technology analyst James Wilson prepared both the original 2006 version of this study, Medical Device Coating (HLC049A), and its 2008 revision (HLC049B).  He is the author of more than 300 articles and several books dealing with science, medicine, technology and business.  Formerly the editor of the Princeton Business Journal and a senior science and technology editor for Hearst Magazines, he is a past member of the National Association of Science Writers and American Medical Writers Association.  He has served on the adjunct faculty of Temple University and on the staffs of Drexel University and the Academy of Natural Sciences.  His related studies for BCC include MST027H Controlled Release Technologies: Established and Emerging Markets and HLC080A Medical Device Sensors: Technologies and Global Markets.

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Note: Reports are discounted or included with certain Memberships. See Membership Options.
 
Published - Nov-2008| Analyst - Jim Wilson| Code - HLC049B

Report Highlights

  • The global medical device coatings market will increase from an estimated $4.2 billion in 2008 to $4.7 billion in 2009. It should reach $7.5 billion in 2014, a compound annual growth rate (CAGR) of 9.9%.
  • The NAFTA region has the largest share of the market with an estimated $2.1 billion in sales in 2008. This is expected to increase to $2.4 billion in 2009 and $3.9 billion in 2014, for a CAGR of 10.2%.
  • The European Union has the second largest share of the market and is expected to generate $1.1 billion in 2008. This should increase slightly in 2009 and reach $2.0 billion in 2014, for a CAGR of 10.6%.
Published - Apr-2006| Analyst - Jim Wilson| Code - HLC049A

Report Highlights

  • The value of worldwide sales for all categories of coatings and surface treatment processes used in manufacturing medical devices reached $2.96 billion in 2005.
  • Fueled by an explosive growth in high-value combination products, such as arterial stents and antimicrobial-coated catheters, the global medical device coatings business will experience an average annual growth rate (AAGR) of 12.4%, reaching worldwide sales of $5.31 billion by 2010.
  • The swift acceptance of drug-eluting stents as a "gold standard" treatment by surgeons around the globe suggests that the demand for other coated versions of existing medical devices will be equally swift. Our analysis further suggests that there will be a correspondingly swift acceptance of new coated devices as they are introduced.
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
RELATED REPORTS
Share This Report